HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Dianzani Selected Research

1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrile

1/2012AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.
1/2012Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Dianzani Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 10/2010
9Melanoma (Melanoma, Malignant)
01/2022 - 12/2013
5Neoplasm Metastasis (Metastasis)
12/2021 - 10/2010
5Urinary Bladder Neoplasms (Bladder Cancer)
10/2020 - 01/2018
5Multiple Sclerosis
01/2019 - 09/2014
5Inflammation (Inflammations)
07/2018 - 07/2006
4Prostatic Neoplasms (Prostate Cancer)
10/2019 - 11/2012
3Breast Neoplasms (Breast Cancer)
12/2021 - 01/2018
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 09/2014
3Reperfusion Injury
04/2013 - 01/2006
3Ischemia
09/2008 - 01/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 11/2018
2Skin Neoplasms (Skin Cancer)
01/2021 - 01/2014
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 02/2018
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2017 - 07/2006
2Autoimmune Diseases (Autoimmune Disease)
01/2016 - 06/2015
2Colonic Neoplasms (Colon Cancer)
01/2012 - 01/2012
2Transient Ischemic Attack
09/2008 - 08/2006
2Stroke (Strokes)
08/2006 - 01/2006
1Multiple Myeloma
01/2022
1Bone Resorption
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Experimental Melanoma
10/2020
1Cardiotoxicity
01/2020
1Relapsing-Remitting Multiple Sclerosis
01/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2018
1Metabolic Bone Diseases (Osteopenia)
07/2018
1Sarcopenia
07/2018
1Drug-Related Side Effects and Adverse Reactions
11/2017
1Anaplastic Thyroid Carcinoma
11/2017
1Colitis
06/2017

Drug/Important Bio-Agent (IBA)

18Pharmaceutical PreparationsIBA
10/2021 - 10/2010
7OsteopontinIBA
12/2021 - 01/2016
5LigandsIBA
01/2022 - 01/2012
5AntioxidantsIBA
03/2021 - 08/2006
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 08/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2016
5CyclodextrinsIBA
11/2017 - 11/2012
4Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2015
44-hydroxy-2-nonenal (4-hydroxynonenal)IBA
01/2019 - 12/2013
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2019
3Glutathione (Reduced Glutathione)IBA
11/2018 - 08/2006
3AldehydesIBA
07/2018 - 12/2013
3Lipid NanoparticlesIBA
01/2018 - 06/2017
3CamptothecinIBA
11/2017 - 11/2012
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2017 - 11/2012
3CytokinesIBA
06/2017 - 01/2016
2Small Interfering RNA (siRNA)IBA
01/2022 - 10/2020
2Biological ProductsIBA
01/2021 - 10/2020
2Interleukin-10 (Interleukin 10)IBA
10/2020 - 09/2014
2Bevacizumab (Avastin)FDA Link
05/2020 - 01/2015
2Temozolomide (Temodar)FDA LinkGeneric
05/2020 - 01/2018
2Messenger RNA (mRNA)IBA
01/2020 - 01/2018
2ailanthoneIBA
01/2020 - 03/2019
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019 - 01/2017
2AntibodiesIBA
01/2019 - 01/2017
2Protein Isoforms (Isoforms)IBA
01/2019 - 01/2016
2ProdrugsIBA
02/2018 - 01/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2017 - 06/2017
2Fatty Acids (Saturated Fatty Acids)IBA
02/2016 - 04/2013
2Rosiglitazone (Avandia)FDA Link
01/2012 - 01/2006
21,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA
01/2012 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2008 - 02/2006
2Staphylococcal Protein A (Protein A)IBA
09/2008 - 08/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2008 - 01/2006
1NF-E2-Related Factor 2IBA
01/2022
1Inducible T-Cell Co-Stimulator ProteinIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2021
1Deubiquitinating EnzymesIBA
10/2021
1Transcription Factors (Transcription Factor)IBA
03/2021
1StrontiumIBA
01/2021
1AlbuminsIBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1Dendrimers (Dendrons)IBA
10/2020
1Guanidine (Guanidine Nitrate)FDA Link
10/2020
1carbosilaneIBA
10/2020
1Drug CombinationsIBA
05/2020
1Sirolimus (Rapamycin)FDA Link
05/2020
16-bromo-2-naphthyl sulfate (BNS)IBA
01/2020
1AnthracyclinesIBA
01/2020
1puag-haadIBA
10/2019
1ResveratrolIBA
10/2019
1Dimethyl FumarateIBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
01/2019
1Plant Growth Regulators (Plant Hormones)IBA
11/2018
1GR24 strigolactoneIBA
11/2018
1Carotenoids (Carotene)IBA
11/2018
1Cytotoxins (Cytolysins)IBA
01/2018
1Floxuridine (FUdR)FDA LinkGeneric
01/2018
1Succinic Acid (Succinate)IBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
1LipopolysaccharidesIBA
06/2017
1Dextran SulfateIBA
06/2017

Therapy/Procedure

13Therapeutics
12/2021 - 07/2006
2Drug Therapy (Chemotherapy)
10/2021 - 05/2020
2Immunotherapy
10/2021 - 10/2020
2Injections
05/2020 - 09/2014
1Radiotherapy
10/2021
1Total Parenteral Nutrition
05/2020